1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Family getting ready to sell

Discussion in 'Mission Pharmacal' started by anonymous, Apr 10, 2019 at 4:20 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Heard that the family is positioning to break apart the company and sell off whatever they can. No more MP.
     
  2. anonymous

    anonymous Guest

    You “heard”...........
    Reliable Source?
    Too good of a family to do that
     
  3. anonymous

    anonymous Guest

    Are you just speculating from observation or did you hear some information from someone that leads you to this conclusion?
     
  4. anonymous

    anonymous Guest

    Not speculating.
     
  5. anonymous

    anonymous Guest

    So then can you expand on your statement?
     
  6. anonymous

    anonymous Guest

    I second aforementioned question. Can you elaborate?
     
  7. anonymous

    anonymous Guest

    ???
     
  8. anonymous

    anonymous Guest

    Heard from where? Legit source?
     
  9. anonymous

    anonymous Guest

    any more news on this?